Exploring the performance of Escherichia coli outer membrane vesicles as a tool for vaccine development against Chagas disease
- Autores
- Vázquez, María Elisa; Mesias, Andrea Cecilia; Acuña, Leonardo; Spangler, Joseph; Zabala, Brenda Adriana; Parodi Ramoneda, Cecilia María; Thakur, Meghna; Oh, Eunkeu; Walper, Scott Allan; Pérez Brandan, Cecilia María
- Año de publicación
- 2023
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- BACKGROUND:Vaccine development is a laborious craftwork in which at least two main components must be defined: a highly immunogenic antigen and a suitable delivery method. Hence, the interplay of these elements could elicit the required immune response to cope with the targeted pathogen with a long-lasting protective capacity.OBJECTIVES:Here we evaluate the properties of Escherichia coli spherical proteoliposomes - known as outer membrane vesicles (OMVs) - as particles with natural adjuvant capacities and as antigen-carrier structures to assemble an innovative prophylactic vaccine for Chagas disease.METHODSTo achieve this, genetic manipulation was carried out on E. coli using an engineered plasmid containing the Tc24 Trypanosoma cruzi antigen. The goal was to induce the release of OMVs displaying the parasite protein on their surface.FINDINGS: As a proof of principle, we observed that native OMVs - as well as those carrying the T. cruzi antigen - were able to trigger a slight, but functional humoral response at low immunization doses. Of note, compared to the non-immunized group, native OMVs-vaccinated animals survived the lethal challenge and showed minor parasitemia values, suggesting a possible involvement of innate trained immunity mechanism.MAIN CONCLUSION: These results open the range for further research on the design of new carrier strategies focused on innate immunity activation as an additional immunization target and venture to seek for alternative forms in which OMVs could be used for optimizing vaccine development.
Fil: Vázquez, María Elisa. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta. Instituto de Patología Experimental. Universidad Nacional de Salta. Facultad de Ciencias de la Salud. Instituto de Patología Experimental; Argentina
Fil: Mesias, Andrea Cecilia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta. Instituto de Patología Experimental. Universidad Nacional de Salta. Facultad de Ciencias de la Salud. Instituto de Patología Experimental; Argentina
Fil: Acuña, Leonardo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta. Instituto de Patología Experimental. Universidad Nacional de Salta. Facultad de Ciencias de la Salud. Instituto de Patología Experimental; Argentina
Fil: Spangler, Joseph. Spece Sciences División. Naval Research Laboratory; Estados Unidos
Fil: Zabala, Brenda Adriana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta. Instituto de Patología Experimental. Universidad Nacional de Salta. Facultad de Ciencias de la Salud. Instituto de Patología Experimental; Argentina
Fil: Parodi Ramoneda, Cecilia María. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta. Instituto de Patología Experimental. Universidad Nacional de Salta. Facultad de Ciencias de la Salud. Instituto de Patología Experimental; Argentina
Fil: Thakur, Meghna. George Mason University; Estados Unidos
Fil: Oh, Eunkeu. Spece Sciences División. Naval Research Laboratory; Estados Unidos
Fil: Walper, Scott Allan. Spece Sciences División. Naval Research Laboratory; Estados Unidos
Fil: Pérez Brandan, Cecilia María. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta. Instituto de Patología Experimental. Universidad Nacional de Salta. Facultad de Ciencias de la Salud. Instituto de Patología Experimental; Argentina - Materia
-
Outer Membrane Vesicles
Trypansosoma cruzi
Vaccine - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/230187
Ver los metadatos del registro completo
id |
CONICETDig_1ea3aa6287fd4e65342695c7dc1180d1 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/230187 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Exploring the performance of Escherichia coli outer membrane vesicles as a tool for vaccine development against Chagas diseaseVázquez, María ElisaMesias, Andrea CeciliaAcuña, LeonardoSpangler, JosephZabala, Brenda AdrianaParodi Ramoneda, Cecilia MaríaThakur, MeghnaOh, EunkeuWalper, Scott AllanPérez Brandan, Cecilia MaríaOuter Membrane VesiclesTrypansosoma cruziVaccinehttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3BACKGROUND:Vaccine development is a laborious craftwork in which at least two main components must be defined: a highly immunogenic antigen and a suitable delivery method. Hence, the interplay of these elements could elicit the required immune response to cope with the targeted pathogen with a long-lasting protective capacity.OBJECTIVES:Here we evaluate the properties of Escherichia coli spherical proteoliposomes - known as outer membrane vesicles (OMVs) - as particles with natural adjuvant capacities and as antigen-carrier structures to assemble an innovative prophylactic vaccine for Chagas disease.METHODSTo achieve this, genetic manipulation was carried out on E. coli using an engineered plasmid containing the Tc24 Trypanosoma cruzi antigen. The goal was to induce the release of OMVs displaying the parasite protein on their surface.FINDINGS: As a proof of principle, we observed that native OMVs - as well as those carrying the T. cruzi antigen - were able to trigger a slight, but functional humoral response at low immunization doses. Of note, compared to the non-immunized group, native OMVs-vaccinated animals survived the lethal challenge and showed minor parasitemia values, suggesting a possible involvement of innate trained immunity mechanism.MAIN CONCLUSION: These results open the range for further research on the design of new carrier strategies focused on innate immunity activation as an additional immunization target and venture to seek for alternative forms in which OMVs could be used for optimizing vaccine development.Fil: Vázquez, María Elisa. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta. Instituto de Patología Experimental. Universidad Nacional de Salta. Facultad de Ciencias de la Salud. Instituto de Patología Experimental; ArgentinaFil: Mesias, Andrea Cecilia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta. Instituto de Patología Experimental. Universidad Nacional de Salta. Facultad de Ciencias de la Salud. Instituto de Patología Experimental; ArgentinaFil: Acuña, Leonardo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta. Instituto de Patología Experimental. Universidad Nacional de Salta. Facultad de Ciencias de la Salud. Instituto de Patología Experimental; ArgentinaFil: Spangler, Joseph. Spece Sciences División. Naval Research Laboratory; Estados UnidosFil: Zabala, Brenda Adriana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta. Instituto de Patología Experimental. Universidad Nacional de Salta. Facultad de Ciencias de la Salud. Instituto de Patología Experimental; ArgentinaFil: Parodi Ramoneda, Cecilia María. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta. Instituto de Patología Experimental. Universidad Nacional de Salta. Facultad de Ciencias de la Salud. Instituto de Patología Experimental; ArgentinaFil: Thakur, Meghna. George Mason University; Estados UnidosFil: Oh, Eunkeu. Spece Sciences División. Naval Research Laboratory; Estados UnidosFil: Walper, Scott Allan. Spece Sciences División. Naval Research Laboratory; Estados UnidosFil: Pérez Brandan, Cecilia María. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta. Instituto de Patología Experimental. Universidad Nacional de Salta. Facultad de Ciencias de la Salud. Instituto de Patología Experimental; ArgentinaFundação Oswaldo Cruz2023-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/230187Vázquez, María Elisa; Mesias, Andrea Cecilia; Acuña, Leonardo; Spangler, Joseph; Zabala, Brenda Adriana; et al.; Exploring the performance of Escherichia coli outer membrane vesicles as a tool for vaccine development against Chagas disease; Fundação Oswaldo Cruz; Memórias do Instituto Oswaldo Cruz; 118; 5-2023; 1-120074-02761678-8060CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1590/0074-02760220263info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:12:32Zoai:ri.conicet.gov.ar:11336/230187instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:12:32.343CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Exploring the performance of Escherichia coli outer membrane vesicles as a tool for vaccine development against Chagas disease |
title |
Exploring the performance of Escherichia coli outer membrane vesicles as a tool for vaccine development against Chagas disease |
spellingShingle |
Exploring the performance of Escherichia coli outer membrane vesicles as a tool for vaccine development against Chagas disease Vázquez, María Elisa Outer Membrane Vesicles Trypansosoma cruzi Vaccine |
title_short |
Exploring the performance of Escherichia coli outer membrane vesicles as a tool for vaccine development against Chagas disease |
title_full |
Exploring the performance of Escherichia coli outer membrane vesicles as a tool for vaccine development against Chagas disease |
title_fullStr |
Exploring the performance of Escherichia coli outer membrane vesicles as a tool for vaccine development against Chagas disease |
title_full_unstemmed |
Exploring the performance of Escherichia coli outer membrane vesicles as a tool for vaccine development against Chagas disease |
title_sort |
Exploring the performance of Escherichia coli outer membrane vesicles as a tool for vaccine development against Chagas disease |
dc.creator.none.fl_str_mv |
Vázquez, María Elisa Mesias, Andrea Cecilia Acuña, Leonardo Spangler, Joseph Zabala, Brenda Adriana Parodi Ramoneda, Cecilia María Thakur, Meghna Oh, Eunkeu Walper, Scott Allan Pérez Brandan, Cecilia María |
author |
Vázquez, María Elisa |
author_facet |
Vázquez, María Elisa Mesias, Andrea Cecilia Acuña, Leonardo Spangler, Joseph Zabala, Brenda Adriana Parodi Ramoneda, Cecilia María Thakur, Meghna Oh, Eunkeu Walper, Scott Allan Pérez Brandan, Cecilia María |
author_role |
author |
author2 |
Mesias, Andrea Cecilia Acuña, Leonardo Spangler, Joseph Zabala, Brenda Adriana Parodi Ramoneda, Cecilia María Thakur, Meghna Oh, Eunkeu Walper, Scott Allan Pérez Brandan, Cecilia María |
author2_role |
author author author author author author author author author |
dc.subject.none.fl_str_mv |
Outer Membrane Vesicles Trypansosoma cruzi Vaccine |
topic |
Outer Membrane Vesicles Trypansosoma cruzi Vaccine |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
BACKGROUND:Vaccine development is a laborious craftwork in which at least two main components must be defined: a highly immunogenic antigen and a suitable delivery method. Hence, the interplay of these elements could elicit the required immune response to cope with the targeted pathogen with a long-lasting protective capacity.OBJECTIVES:Here we evaluate the properties of Escherichia coli spherical proteoliposomes - known as outer membrane vesicles (OMVs) - as particles with natural adjuvant capacities and as antigen-carrier structures to assemble an innovative prophylactic vaccine for Chagas disease.METHODSTo achieve this, genetic manipulation was carried out on E. coli using an engineered plasmid containing the Tc24 Trypanosoma cruzi antigen. The goal was to induce the release of OMVs displaying the parasite protein on their surface.FINDINGS: As a proof of principle, we observed that native OMVs - as well as those carrying the T. cruzi antigen - were able to trigger a slight, but functional humoral response at low immunization doses. Of note, compared to the non-immunized group, native OMVs-vaccinated animals survived the lethal challenge and showed minor parasitemia values, suggesting a possible involvement of innate trained immunity mechanism.MAIN CONCLUSION: These results open the range for further research on the design of new carrier strategies focused on innate immunity activation as an additional immunization target and venture to seek for alternative forms in which OMVs could be used for optimizing vaccine development. Fil: Vázquez, María Elisa. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta. Instituto de Patología Experimental. Universidad Nacional de Salta. Facultad de Ciencias de la Salud. Instituto de Patología Experimental; Argentina Fil: Mesias, Andrea Cecilia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta. Instituto de Patología Experimental. Universidad Nacional de Salta. Facultad de Ciencias de la Salud. Instituto de Patología Experimental; Argentina Fil: Acuña, Leonardo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta. Instituto de Patología Experimental. Universidad Nacional de Salta. Facultad de Ciencias de la Salud. Instituto de Patología Experimental; Argentina Fil: Spangler, Joseph. Spece Sciences División. Naval Research Laboratory; Estados Unidos Fil: Zabala, Brenda Adriana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta. Instituto de Patología Experimental. Universidad Nacional de Salta. Facultad de Ciencias de la Salud. Instituto de Patología Experimental; Argentina Fil: Parodi Ramoneda, Cecilia María. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta. Instituto de Patología Experimental. Universidad Nacional de Salta. Facultad de Ciencias de la Salud. Instituto de Patología Experimental; Argentina Fil: Thakur, Meghna. George Mason University; Estados Unidos Fil: Oh, Eunkeu. Spece Sciences División. Naval Research Laboratory; Estados Unidos Fil: Walper, Scott Allan. Spece Sciences División. Naval Research Laboratory; Estados Unidos Fil: Pérez Brandan, Cecilia María. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta. Instituto de Patología Experimental. Universidad Nacional de Salta. Facultad de Ciencias de la Salud. Instituto de Patología Experimental; Argentina |
description |
BACKGROUND:Vaccine development is a laborious craftwork in which at least two main components must be defined: a highly immunogenic antigen and a suitable delivery method. Hence, the interplay of these elements could elicit the required immune response to cope with the targeted pathogen with a long-lasting protective capacity.OBJECTIVES:Here we evaluate the properties of Escherichia coli spherical proteoliposomes - known as outer membrane vesicles (OMVs) - as particles with natural adjuvant capacities and as antigen-carrier structures to assemble an innovative prophylactic vaccine for Chagas disease.METHODSTo achieve this, genetic manipulation was carried out on E. coli using an engineered plasmid containing the Tc24 Trypanosoma cruzi antigen. The goal was to induce the release of OMVs displaying the parasite protein on their surface.FINDINGS: As a proof of principle, we observed that native OMVs - as well as those carrying the T. cruzi antigen - were able to trigger a slight, but functional humoral response at low immunization doses. Of note, compared to the non-immunized group, native OMVs-vaccinated animals survived the lethal challenge and showed minor parasitemia values, suggesting a possible involvement of innate trained immunity mechanism.MAIN CONCLUSION: These results open the range for further research on the design of new carrier strategies focused on innate immunity activation as an additional immunization target and venture to seek for alternative forms in which OMVs could be used for optimizing vaccine development. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-05 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/230187 Vázquez, María Elisa; Mesias, Andrea Cecilia; Acuña, Leonardo; Spangler, Joseph; Zabala, Brenda Adriana; et al.; Exploring the performance of Escherichia coli outer membrane vesicles as a tool for vaccine development against Chagas disease; Fundação Oswaldo Cruz; Memórias do Instituto Oswaldo Cruz; 118; 5-2023; 1-12 0074-0276 1678-8060 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/230187 |
identifier_str_mv |
Vázquez, María Elisa; Mesias, Andrea Cecilia; Acuña, Leonardo; Spangler, Joseph; Zabala, Brenda Adriana; et al.; Exploring the performance of Escherichia coli outer membrane vesicles as a tool for vaccine development against Chagas disease; Fundação Oswaldo Cruz; Memórias do Instituto Oswaldo Cruz; 118; 5-2023; 1-12 0074-0276 1678-8060 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1590/0074-02760220263 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Fundação Oswaldo Cruz |
publisher.none.fl_str_mv |
Fundação Oswaldo Cruz |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844614033729126400 |
score |
13.070432 |